Table 3.
Category |
Status of medicines at home (n = 821) |
|||
---|---|---|---|---|
Current use | Leftover | Anticipated future use | Total (%) | |
Analgesics |
90 (10.9%) |
42 (5.1%) |
29 (3.5%) |
161 (19.6%) |
Antimalarials |
42 (5.1%) |
43 (5.2%) |
43 (5.2%) |
128 (15.6%) |
Antibacterial |
153 (18.6%) |
122 (14.9%) |
54 (6.6%) |
329 (40.1%) |
Antihelminth |
1 (0.1%) |
3 (0.4%) |
5 (0.6%) |
9 (1.2%) |
Antifungals |
6 (0.7%) |
6 (0.7%) |
2 (0.2%) |
14 (1.7%) |
Antiretrovirals |
34 (4.1%) |
- |
- |
34 (4.7%) |
Nutrient supplements |
13 (1.6%) |
6 (0.7%) |
4 (0.5%) |
23 (2.8%) |
GIT drugs |
21 (2.6%) |
8 (1.0%) |
7 (0.9%) |
36 (4.4%) |
Antihypertensives |
3 (0.4%) |
- |
1 (0.1%) |
4 (0.5%) |
Antidiabetic drugs |
3 (0.4%) |
- |
- |
3 (0.4%) |
Corticosteroids |
5 (0.6%) |
2 (0.2%) |
2 (0.2%) |
9 (1.1%) |
Antihistamines |
12 (1.5%) |
8 (1.0%) |
6 (0.7%) |
26 (3.2%) |
Others |
13 (1.6%) |
20 (2.4%) |
12 (1.5%) |
45 (5.5%) |
Total | 396 (48.2%) | 260 (31.7%) | 165 (20.1%) | 821 (100%) |
%: Percentage, n: sample size.